EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Methadone Dose and Patient-Directed Discharge in Hospitalized Patients With Opioid Use Disorder

Methadon-Dosis und patient:innengesteuerte Entlassung bei hospitalisierten Patient:innen mit Opioidkonsumstörung

Rebecca R Meredith, William M Garneau, Kenneth A Feder, Megan E Buresh

JAMA Network Open · 25.03.2026 · 9 (3) · e263439

DOI: 10.1001/jamanetworkopen.2026.3439 ↗

Auf einen Blick

Bei hospitalisierten Erwachsenen mit Opioidkonsumstörung war eine höhere Methadon-Gesamtdosis in den ersten 24 Stunden mit geringerer patient:innengesteuerter Entlassung verbunden. Ähnliche Ergebnisse zeigten sich für 72, 96 Stunden und „ever“.

Fragestellung

Ob höhere Methadon-Dosen in den ersten 24, 48 und 72 Stunden nach Erstkontakt in der Notaufnahme mit geringeren Chancen für patient:innengesteuerte Entlassung verbunden sind.

Methode

Retrospektive Beobachtungs-Kohortenstudie an einem universitären Zentrum im Nordosten der USA (1. Juli 2019 bis 30. Juni 2022). Eingeschlossen wurden Erwachsene mit OUD ohne Methadon in der Medikamentenanamnese, die in den ersten 72 Stunden Methadon erhielten.

Ergebnisse

554 Patient:innen. In der 24-Stunden-Kohorte (325) lag PDD bei 45 Patient:innen (13,8 %). Pro weitere 10 mg Methadon in den ersten 24 Stunden: aOR 0,71 (95 %-KI 0,44–0,98) für PDD nach 48 Stunden; ähnlich für 72 Stunden, 96 Stunden und ever.

Schlussfolgerung der Autor:innen

Höhere kumulative Methadon-Dosen in den ersten 48 Stunden waren mit deutlichen Reduktionen der patient:innengesteuerten Entlassung verbunden. Die Autor:innen sehen frühe und ausreichende Methadon-Behandlung als potenziell relevant.

Kernaussagen

  • 325 Patient:innen in der 24-Stunden-Kohorte; PDD bei 13,8 %
  • Pro 10 mg Methadon: aOR 0,71 (95 %-KI 0,44–0,98)
  • Weitere Analysen zeigten ähnliche oder schwächere Zusammenhänge

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Beobachtungsstudie in der Zeitschrift JAMA Network Open, online erschienen am 25.03.2026. Verfasst von Rebecca R Meredith und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hospital Medicine, Department of Medicine, Johns Hopkins Hospital, Baltimore, Maryland. Hauptthemen laut MEDLINE: Methadone, Patient Discharge, Opioid-Related Disorders, Analgesics, Opioid. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Patient-directed discharge (PDD), when patients leave the hospital prior to completing recommended medical treatment, is associated with increased morbidity and mortality and occurs in 10% to 20% of hospitalizations for patients with opioid use disorder (OUD). Understanding risk factors associated with PDD is essential to improving outcomes for this population.

Objective

To investigate whether hospitalized patients with OUD who received higher doses of methadone during the first 24, 48, and 72 hours after first contact with the emergency department had decreased odds of PDD. Design, Setting, and Participants This retrospective observational cohort study was conducted at a single academic health center in the northeastern US during the fentanyl era (July 1, 2019, to June 30, 2022). Hospitalized adults with OUD and without methadone listed in their medication history who received methadone during the first 72 hours were included. Data were analyzed from April 2025 through February 2026. Exposures Cumulative dose of methadone received for patients 24, 48, and 72 hours after initial evaluation in the emergency department. Main Outcomes and Measures PDD by 48, 72, or 96 hours or ever, as indicated by discharge disposition in the patient electronic health record.

Results

A total of 554 patients were included in the study. For analysis, participants were separated into cohorts based on cumulative dose by 24 hours (325 patients), 48 hours (488 patients), and 72 hours (454 patients) after presentation to the emergency department, with the main analysis among patients in the 24-hour cohort. Among 325 patients (184 male [56.6%]; median [IQR] age, 49.0 [36.0-59.0] years) receiving methadone within 24 hours of presentation to the emergency department, the incidence of PDD was 45 patients (13.8%). In an adjusted logistic regression model, each additional 10 mg of methadone in the first 24 hours was associated with lower odds of PDD (adjusted odds ratio [aOR], 0.71; 95% CI, 0.44-0.98) at 48 hours. Results were similar for PDD at 72 hours (aOR, 0.68; 95% CI, 0.50-0.85), 96 hours (aOR, 0.72; 95% CI, 0.56-0.88), or ever (aOR, 0.79; 95% CI, 0.67-0.91) in the 24-hour cohort and qualitatively similar but with smaller decreases in odds or nonsignificant outcomes for cumulative methadone dose in the 48-hour cohort (eg, PDD at 96 hours: aOR, 0.91; 95% CI, 0.82-0.99) and nonsignificant outcomes in the 72-hour cohort (eg, PDD at 96 hours: aOR, 0.98; 95% CI, 0.89-1.06). Conclusions and Relevance In this study, higher cumulative doses of methadone during the first 48 hours of care were associated with substantial reductions in the incidence of PDD. These findings suggest that early and adequate treatment of withdrawal with methadone may be associated with reduced PDD among hospitalized patients with OUD in the fentanyl era.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethadonePatient DischargeOpioid-Related DisordersAnalgesics, OpioidHumansRetrospective StudiesMaleMiddle AgedFemaleAdultHospitalizationEmergency Service, HospitalDose-Response Relationship, Drug

Substanzen

MethadoneAnalgesics, Opioid

Autor:innen und Institutionen

  • Division of Hospital Medicine, Department of Medicine, Johns Hopkins Hospital, Baltimore, Maryland.
  • Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Division of Addiction Medicine, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland.

Zitieren

APA

Meredith, R. R., Garneau, W. M., Feder, K. A., & Buresh, M. E. (2026). Methadone Dose and Patient-Directed Discharge in Hospitalized Patients With Opioid Use Disorder. JAMA Network Open, 9(3), e263439. https://doi.org/10.1001/jamanetworkopen.2026.3439

Vancouver

Meredith RR, Garneau WM, Feder KA, Buresh ME. Methadone Dose and Patient-Directed Discharge in Hospitalized Patients With Opioid Use Disorder. JAMA Network Open. 2026;9(3):e263439. doi:10.1001/jamanetworkopen.2026.3439

BibTeX
@article{Meredith2026,
  author = {Meredith, Rebecca R and Garneau, William M and Feder, Kenneth A and Buresh, Megan E},
  title = {Methadone Dose and Patient-Directed Discharge in Hospitalized Patients With Opioid Use Disorder},
  journal = {JAMA Network Open},
  year = {2026},
  volume = {9},
  number = {3},
  pages = {e263439},
  doi = {10.1001/jamanetworkopen.2026.3439}
}
Kostenlos starten →